In addition, fusion protein complexes combining IL-12, IL-15, and IL-18 signaling have been developed and validated in an in vivo model, which could promote memory-type differentiation of NK cells and improve their metabolism as well as enhancing anti-tumor cytotoxicity such as secretion of IFN-γ in the short term. This evidence concerns the gene IL18 and neoplasm.